Isabella Brooke Knightly and Austin Gamez-Knightly
In Memory of my Loving Husband, William F. Knightly Jr. Murdered by ILLEGAL Palliative Care at a Nashua, NH Hospital
Sunday, September 19, 2010
Baby LK Report for September 19th 2010 - There's something a little fishy going on around here
http://www.youtube.com/watch?v=AA6iYT2UoIQ&feature=player_embedded#!
$1,000 a Pop: How Forest Labs Bribed Doctors to Prescribe Antidepressants to Kids
$1,000 a Pop: How Forest Labs Bribed Doctors to Prescribe Antidepressants to Kids
By Jim Edwards | September 15, 2010 6 Comments
Placebo Effect
Jim Edwards
Forest Labs (FRX) appears to have initially underestimated how much it needed to pay the feds to go away: In 2009, the company said it had set aside $170 million in case it needed to settle a Department of Justice investigation of the kickbacks it paid in its marketing of Celexa and Lexapro, two antidepressants. Today, the company paid $313 million to wrap up the probes.
Forest’s management is used to lavish spending, however, as the whistleblower complaints behind the settlement allege.
The meat of Forest’s wrongdoing is that the company promoted Celexa for children even though the FDA had specifically rejected the drug for kids, and even though European data showed it was not useful in youths. The company did something similar with Lexapro — one pharmaceutical sales rep recommended crushing up Lexapro into apple sauce in order to make it more palatable to children.
Forest overcame resistance to the pediatric use of its antidepressants by bribing doctors with cash and gifts, the lawsuits alleged.
Read the entire article at:http://www.bnet.com/blog/drug-business/1000-a-pop-how-forest-labs-bribed-doctors-to-prescribe-antidepressants-to-kids/5753
By Jim Edwards | September 15, 2010 6 Comments
Placebo Effect
Jim Edwards
Forest Labs (FRX) appears to have initially underestimated how much it needed to pay the feds to go away: In 2009, the company said it had set aside $170 million in case it needed to settle a Department of Justice investigation of the kickbacks it paid in its marketing of Celexa and Lexapro, two antidepressants. Today, the company paid $313 million to wrap up the probes.
Forest’s management is used to lavish spending, however, as the whistleblower complaints behind the settlement allege.
The meat of Forest’s wrongdoing is that the company promoted Celexa for children even though the FDA had specifically rejected the drug for kids, and even though European data showed it was not useful in youths. The company did something similar with Lexapro — one pharmaceutical sales rep recommended crushing up Lexapro into apple sauce in order to make it more palatable to children.
Forest overcame resistance to the pediatric use of its antidepressants by bribing doctors with cash and gifts, the lawsuits alleged.
Read the entire article at:http://www.bnet.com/blog/drug-business/1000-a-pop-how-forest-labs-bribed-doctors-to-prescribe-antidepressants-to-kids/5753
Common Drugs for Adhd May Cause Hallucinations- the Latest Fda Warning
Common Drugs for Adhd May Cause Hallucinations- the Latest Fda Warning
by SeeMidTN.com (aka Brent)
Common Drugs for Adhd May Cause Hallucinations- the Latest Fda Warning
Let us have a look at the latest offering from the FDA on common drugs for ADHD. First what are the drugs for ADHD? Dexadrine, Strattera, Ritalin, Adderall XR and Metadate, just to name a few. And the latest news is that the FDA has now warned that children on these ADHD drugs may have hallucinations about insects, snakes and worms crawling all over them! They found 850 cases of this latest horror in the ADHD drugs saga – actually that represents about 2% of the children taking these drugs. These are rather coyly referred to as hallucinations and ‘psychotic episodes’. One little girl actually fell down because she was convinced she had run into a brick wall. She had taken a 18 milligrams dose of one of the above drugs.
You can find this report in the ‘Pediatrics’ journal. As if that was not enough, there are reports of children on Strattera (one of the drugs incriminated above) having suicidal thoughts. Not surprising if they think worms are crawling all over them ! Now, when we realize that there are now millions of children in the USA alone on these drugs, about 8% on the latest count, then there is a case for a high alert to be issued. Especially when you add in the other side effects of these common drugs for ADHD, you begin to wonder what on earth are we doing to our children?
Read the entire article at:
http://www.drug-rehab-people.com/common-drugs-for-adhd-may-cause-hallucinations-the-latest-fda-warning/
by SeeMidTN.com (aka Brent)
Common Drugs for Adhd May Cause Hallucinations- the Latest Fda Warning
Let us have a look at the latest offering from the FDA on common drugs for ADHD. First what are the drugs for ADHD? Dexadrine, Strattera, Ritalin, Adderall XR and Metadate, just to name a few. And the latest news is that the FDA has now warned that children on these ADHD drugs may have hallucinations about insects, snakes and worms crawling all over them! They found 850 cases of this latest horror in the ADHD drugs saga – actually that represents about 2% of the children taking these drugs. These are rather coyly referred to as hallucinations and ‘psychotic episodes’. One little girl actually fell down because she was convinced she had run into a brick wall. She had taken a 18 milligrams dose of one of the above drugs.
You can find this report in the ‘Pediatrics’ journal. As if that was not enough, there are reports of children on Strattera (one of the drugs incriminated above) having suicidal thoughts. Not surprising if they think worms are crawling all over them ! Now, when we realize that there are now millions of children in the USA alone on these drugs, about 8% on the latest count, then there is a case for a high alert to be issued. Especially when you add in the other side effects of these common drugs for ADHD, you begin to wonder what on earth are we doing to our children?
Read the entire article at:
http://www.drug-rehab-people.com/common-drugs-for-adhd-may-cause-hallucinations-the-latest-fda-warning/
HOUSE BILL 1536-FN AN ACT relative to administering psychotropic drugs to children in court ordered placements.
http://gencourt.state.nh.us/house/committees/HouseBillsInCommittee.aspx?code=H37
HB 1536-FN – AS INTRODUCED
2010 SESSION September 21, 2010 at 10:30 AM Room 207 in the Legislative office Building in Concord. The Public is welcome.
10-2041
05/04
HOUSE BILL 1536-FN
AN ACT relative to administering psychotropic drugs to children in court ordered placements.
SPONSORS: Rep. B. Richardson, Ches 5; Rep. Gile, Merr 10; Rep. Gargasz, Hills 5; Rep.�Julie�Brown, Straf 1; Rep. Ford, Graf 3
COMMITTEE: Children and Family Law
ANALYSIS
This bill requires the department of health and human services to obtain parental consent or a court order, supported by a medical diagnosis and treatment recommendation, prior to administering psychotropic medications to children in court ordered placements.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
10-2041
05/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Ten
AN ACT relative to administering psychotropic drugs to children in court ordered placements.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Subdivision; Court Ordered Placements; Medical and Psychological Care of Children in Court Ordered Placements. Amend RSA 169-F by inserting after section 4 the following new subdivision:
Medical and Psychological Care of Children in Court Ordered Placements
169-F:5 Definitions. In this chapter:
I. “Department” means the department of health and human services.
II. “Physician” shall mean a pediatric child psychiatrist licensed to practice in New�Hampshire.
III. “Psychotropic medication” means those medications the prescribed intention of which is to alter mental activity or mental state, including but not limited to, antipsychotic, antidepressant, and anxiolytic medications, and behavior-altering medications.
169-F:6 Parental Consent for Administration of Psychotropic Medication.
I. Except as otherwise provided in 169-F:7 or RSA 169-F:10, before the department provides psychotropic medications to a child in its custody, the prescribing physician shall attempt to obtain express and informed consent from the child’s parent or legal guardian. The department shall take steps necessary to facilitate the inclusion of the parent in the child’s consultation with the physician. However, if the parental rights of the parent have been terminated, the parent’s location or identity is unknown or cannot reasonably be ascertained, or the parent declines to give express and informed consent, the department may, after consultation with the prescribing physician, seek court authorization to provide the psychotropic medications to the child. Unless parental rights have been terminated and if it is possible to do so, the department shall continue to involve the parent in the decision-making process regarding the provision of psychotropic medications. If, at any time, a parent whose parental rights have not been terminated provides express and informed consent to the provision of a psychotropic medication, the requirements of this subdivision that the department seek court authorization do not apply to that medication until such time as the parent no longer consents.
II. Any time the department seeks a medical evaluation to determine the need to initiate or continue a psychotropic medication for a child, the department shall provide to the evaluating physician all pertinent medical information known to the department concerning that child.
169-F:7 Limited Exceptions to Parental Consent.
I. If a child is removed from the home under RSA 169-B, 169-C, or 169-D and is receiving prescribed psychotropic medication at the time of removal and parental authorization to continue providing the medication cannot be obtained, the department may take possession of the remaining medication and may continue to provide the medication as prescribed until the preliminary hearing, if it is determined that the medication is a current prescription for that child, the medication has been approved by the Food and Drug Administration (FDA) for children of that age, and the medication is in its original container.
II. If the department continues to provide the psychotropic medication to a child when parental authorization cannot be obtained, the department shall notify the parent or legal guardian as soon as possible that the medication is being provided to the child as provided in paragraph I. The department’s case record shall include the reason parental authorization was not initially obtained and an explanation of why the medication is necessary for the child’s well-being.
III. If the department is advised by a licensed physician that the child should continue the psychotropic medication and parental authorization has not been obtained, the department shall request authorization at the preliminary hearing to continue to provide the psychotropic medication and shall provide to the court any information in its possession in support of the request. Any authorization granted at the hearing may extend only until the adjudicatory or dispositional hearing.
169-F:8 Court Authorization and Medical Report Required. Except as provided in RSA 169-F:7 or RSA 169-F:10, the department shall file a motion seeking the court’s authorization to initially provide or continue to provide psychotropic medication to a child in its legal custody. The motion shall be supported by a written report prepared by the department which describes the efforts made to enable the prescribing physician to obtain express and informed consent from the parent and other treatments considered or recommended for the child. In addition, the motion shall be supported by the prescribing physician’s signed medical report providing:
I. The name of the child, the name and range of the dosage of the psychotropic medication, and that there is a need to prescribe psychotropic medication to the child based upon a diagnosed condition for which such medication is being prescribed.
II. A statement indicating that the physician has reviewed all medical information concerning the child which has been provided.
III. A statement indicating that the psychotropic medication has been approved by the FDA for children of that age and, at its prescribed dosage, is appropriate for treating the child’s diagnosed medical condition, as well as the behaviors and symptoms the medication, at its prescribed dosage, is expected to address.
IV. An explanation of the nature and purpose of the treatment; the recognized side effects, risks, and contraindications of the medication; drug-interaction precautions; the possible effects of stopping the medication; and how the treatment will be monitored, followed by a statement indicating that this explanation was provided to the child if age appropriate and to the child’s caregiver.
V. Documentation addressing whether the psychotropic medication will replace or supplement any other currently prescribed medications or treatments; the length of time the child is expected to be taking the medication; and any additional medical, mental health, behavioral, counseling, or other services that the prescribing physician recommends.
169-F:9 Notice and Hearing Regarding Treatment.
I. If any party objects to a motion filed under RSA 169-F:8, that party shall file the objection within 2 working days after being notified of the department’s motion. If any party files an objection, the court shall hold a hearing as soon as possible before authorizing the department to initially provide or to continue providing psychotropic medication to a child in the legal custody of the department. At such hearing, the medical report described in RSA 169-F:8 is admissible in evidence. The prescribing physician need not attend the hearing or testify unless the court specifically orders such attendance or testimony, or a party subpoenas the physician to attend the hearing or provide testimony. If, after considering any testimony received, the court finds that the department’s motion and the physician’s medical report meet the requirements of RSA 169-F:8 and that it is in the child’s best interests, the court may order that the department provide or continue to provide the psychotropic medication to the child without additional testimony or evidence. At any hearing held under this paragraph, the court shall further inquire of the department as to whether additional medical, mental health, behavioral, counseling, or other services are being provided to the child by the department which the prescribing physician considers to be necessary or beneficial in treating the child’s medical condition and which the physician recommends or expects to provide to the child in concert with the medication. The court may order additional medical consultation or require the department to obtain a second opinion within a reasonable timeframe as established by the court, not to exceed 21 calendar days, after such order based upon consideration of the best interests of the child. The department shall make a referral for an appointment for a second opinion with a physician within one working day. The court may not order the discontinuation of prescribed psychotropic medication if such order is contrary to the decision of the prescribing physician unless the court first obtains an opinion from a licensed physician stating that more likely than not, discontinuing the medication would not cause significant harm to the child. The court may also order the discontinuation of prescribed psychotropic medication if a child’s treating physician states that continuing the prescribed psychotropic medication would cause significant harm to the child due to a diagnosed, non-psychiatric medical condition.
II. The burden of proof at any hearing held under this paragraph shall be by a preponderance of the evidence.
169-F:10 Emergency Authorization.
I. If the child’s prescribing physician certifies in the signed medical report required in RSA�169-F:8 that delay in providing a prescribed psychotropic medication would more likely than not cause significant harm to the child, the medication may be provided in advance of the issuance of a court order. In such event, the medical report shall provide the specific reasons why the child may experience significant harm and the nature and the extent of the potential harm. The department shall submit a motion seeking continuation of the medication and the physician’s medical report to the court, the child’s guardian ad litem, and all other parties within 3 working days after the department commences providing the medication to the child. The department shall seek the order at the next regularly scheduled court hearing or within 30 days after the date of the prescription, whichever occurs sooner. If any party objects to the department’s motion, the court shall hold a hearing within 7 days.
II. Psychotropic medications may be administered in advance of a court order in children’s hospitals and inpatient psychiatric programs specializing in mental health care for children and adolescents. Within 3 working days after the medication is begun, the department shall seek court authorization as described in RSA 169-F:8.
169-F:11 Status Report; Court Authorization to Continue Treatment.
I. The department shall fully inform the court of the child’s medical and behavioral status as part of the social services report prepared for each review hearing held for a child for whom psychotropic medication has been prescribed or provided under this subdivision. As a part of the information provided to the court, the department shall furnish copies of all pertinent medical records concerning the child which have been generated since the previous hearing.
II. The court may, in the best interests of the child, order the department to obtain a medical opinion addressing whether the continued use of the medication under the circumstances is safe and medically appropriate.
III. The court shall not authorize a psychotropic medication for a child if the medication has not been approved by the FDA for children of that age.
169-F:12 Rulemaking. The department shall adopt rules under RSA 541-A to ensure that children receive timely access to clinically appropriate psychotropic medications. These rules shall include, but need not be limited to:
I. The process for determining which adjunctive services are needed.
II. The uniform process for facilitating the prescribing physician’s ability to obtain the express and informed consent of a child’s parent or guardian.
III. The procedures for obtaining court authorization for the provision of a psychotropic medication.
IV. The frequency of medical monitoring and reporting on the status of the child to the court.
V. How the child’s parents will be involved in the treatment-planning process if their parental rights have not been terminated.
VI. How caretakers are to be provided information contained in the physician’s signed medical report.
VII. Uniform forms to be used in requesting court authorization for the use of a psychotropic medication and provide for the integration of each child’s treatment plan and case plan.
2 Effective Date. This act shall take effect January 1, 2011.
LBAO
10-2041
12/01/09
HB 1536-FN - FISCAL NOTE
AN ACT relative to administering psychotropic drugs to children in court ordered placements.
FISCAL IMPACT:
The Department of Health and Human Services states this bill may increase state expenditures by an indeterminable amount in FY 2011 and each year thereafter. This bill will have no fiscal impact on state, county and local revenue, or county and local expenditures.
METHODOLOGY:
The Department of Health and Human Services (DHHS) states this bill provides for a number of motions, evaluations, reports and hearings that would be required at various states of the process whenever psychotropic medications are to be provided for a child that is in the Department’s legal custody. The Department states while it is likely the bill would increase the number of motions and hearings in these cases and that it would increase provider costs by prescribing the type, number and timing of evaluations, given the number of variables in the bill, DHHS is unable to estimate what the increase in costs or the Federal and State share of such costs. Although an exact fiscal impact cannot be determined at this time, the Department has analyzed the potential impact as it relates to the population at the Sununu Youth Services Center (SYSC). The Department states after extensive conversation with the staff psychiatrist at the SYSC, there could be additional costs of approximately $1,087.50 per case. Such costs would include psychiatrist report writing; copying of youth medical files; transcription of reports, and review and correction by psychiatrist; psychiatrist meetings with Division of Juvenile Justice Services staff attorney; and psychiatrist court time. DHHS projects the number of SYSC cases impacted would total 13 in FY 2011, 14 in FY 2012, and 15 in FY 2013 and each year thereafter, which would result in additional costs of approximately $14,138 in FY 2011, $15,225 in FY 2012, and $16,313 in FY 2013 and beyond. All such costs would be from the state general fund since youth in placement at SYSC are not eligible for federal reimbursement (Title IV-E).
HB 1536-FN – AS INTRODUCED
2010 SESSION September 21, 2010 at 10:30 AM Room 207 in the Legislative office Building in Concord. The Public is welcome.
10-2041
05/04
HOUSE BILL 1536-FN
AN ACT relative to administering psychotropic drugs to children in court ordered placements.
SPONSORS: Rep. B. Richardson, Ches 5; Rep. Gile, Merr 10; Rep. Gargasz, Hills 5; Rep.�Julie�Brown, Straf 1; Rep. Ford, Graf 3
COMMITTEE: Children and Family Law
ANALYSIS
This bill requires the department of health and human services to obtain parental consent or a court order, supported by a medical diagnosis and treatment recommendation, prior to administering psychotropic medications to children in court ordered placements.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
10-2041
05/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Ten
AN ACT relative to administering psychotropic drugs to children in court ordered placements.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Subdivision; Court Ordered Placements; Medical and Psychological Care of Children in Court Ordered Placements. Amend RSA 169-F by inserting after section 4 the following new subdivision:
Medical and Psychological Care of Children in Court Ordered Placements
169-F:5 Definitions. In this chapter:
I. “Department” means the department of health and human services.
II. “Physician” shall mean a pediatric child psychiatrist licensed to practice in New�Hampshire.
III. “Psychotropic medication” means those medications the prescribed intention of which is to alter mental activity or mental state, including but not limited to, antipsychotic, antidepressant, and anxiolytic medications, and behavior-altering medications.
169-F:6 Parental Consent for Administration of Psychotropic Medication.
I. Except as otherwise provided in 169-F:7 or RSA 169-F:10, before the department provides psychotropic medications to a child in its custody, the prescribing physician shall attempt to obtain express and informed consent from the child’s parent or legal guardian. The department shall take steps necessary to facilitate the inclusion of the parent in the child’s consultation with the physician. However, if the parental rights of the parent have been terminated, the parent’s location or identity is unknown or cannot reasonably be ascertained, or the parent declines to give express and informed consent, the department may, after consultation with the prescribing physician, seek court authorization to provide the psychotropic medications to the child. Unless parental rights have been terminated and if it is possible to do so, the department shall continue to involve the parent in the decision-making process regarding the provision of psychotropic medications. If, at any time, a parent whose parental rights have not been terminated provides express and informed consent to the provision of a psychotropic medication, the requirements of this subdivision that the department seek court authorization do not apply to that medication until such time as the parent no longer consents.
II. Any time the department seeks a medical evaluation to determine the need to initiate or continue a psychotropic medication for a child, the department shall provide to the evaluating physician all pertinent medical information known to the department concerning that child.
169-F:7 Limited Exceptions to Parental Consent.
I. If a child is removed from the home under RSA 169-B, 169-C, or 169-D and is receiving prescribed psychotropic medication at the time of removal and parental authorization to continue providing the medication cannot be obtained, the department may take possession of the remaining medication and may continue to provide the medication as prescribed until the preliminary hearing, if it is determined that the medication is a current prescription for that child, the medication has been approved by the Food and Drug Administration (FDA) for children of that age, and the medication is in its original container.
II. If the department continues to provide the psychotropic medication to a child when parental authorization cannot be obtained, the department shall notify the parent or legal guardian as soon as possible that the medication is being provided to the child as provided in paragraph I. The department’s case record shall include the reason parental authorization was not initially obtained and an explanation of why the medication is necessary for the child’s well-being.
III. If the department is advised by a licensed physician that the child should continue the psychotropic medication and parental authorization has not been obtained, the department shall request authorization at the preliminary hearing to continue to provide the psychotropic medication and shall provide to the court any information in its possession in support of the request. Any authorization granted at the hearing may extend only until the adjudicatory or dispositional hearing.
169-F:8 Court Authorization and Medical Report Required. Except as provided in RSA 169-F:7 or RSA 169-F:10, the department shall file a motion seeking the court’s authorization to initially provide or continue to provide psychotropic medication to a child in its legal custody. The motion shall be supported by a written report prepared by the department which describes the efforts made to enable the prescribing physician to obtain express and informed consent from the parent and other treatments considered or recommended for the child. In addition, the motion shall be supported by the prescribing physician’s signed medical report providing:
I. The name of the child, the name and range of the dosage of the psychotropic medication, and that there is a need to prescribe psychotropic medication to the child based upon a diagnosed condition for which such medication is being prescribed.
II. A statement indicating that the physician has reviewed all medical information concerning the child which has been provided.
III. A statement indicating that the psychotropic medication has been approved by the FDA for children of that age and, at its prescribed dosage, is appropriate for treating the child’s diagnosed medical condition, as well as the behaviors and symptoms the medication, at its prescribed dosage, is expected to address.
IV. An explanation of the nature and purpose of the treatment; the recognized side effects, risks, and contraindications of the medication; drug-interaction precautions; the possible effects of stopping the medication; and how the treatment will be monitored, followed by a statement indicating that this explanation was provided to the child if age appropriate and to the child’s caregiver.
V. Documentation addressing whether the psychotropic medication will replace or supplement any other currently prescribed medications or treatments; the length of time the child is expected to be taking the medication; and any additional medical, mental health, behavioral, counseling, or other services that the prescribing physician recommends.
169-F:9 Notice and Hearing Regarding Treatment.
I. If any party objects to a motion filed under RSA 169-F:8, that party shall file the objection within 2 working days after being notified of the department’s motion. If any party files an objection, the court shall hold a hearing as soon as possible before authorizing the department to initially provide or to continue providing psychotropic medication to a child in the legal custody of the department. At such hearing, the medical report described in RSA 169-F:8 is admissible in evidence. The prescribing physician need not attend the hearing or testify unless the court specifically orders such attendance or testimony, or a party subpoenas the physician to attend the hearing or provide testimony. If, after considering any testimony received, the court finds that the department’s motion and the physician’s medical report meet the requirements of RSA 169-F:8 and that it is in the child’s best interests, the court may order that the department provide or continue to provide the psychotropic medication to the child without additional testimony or evidence. At any hearing held under this paragraph, the court shall further inquire of the department as to whether additional medical, mental health, behavioral, counseling, or other services are being provided to the child by the department which the prescribing physician considers to be necessary or beneficial in treating the child’s medical condition and which the physician recommends or expects to provide to the child in concert with the medication. The court may order additional medical consultation or require the department to obtain a second opinion within a reasonable timeframe as established by the court, not to exceed 21 calendar days, after such order based upon consideration of the best interests of the child. The department shall make a referral for an appointment for a second opinion with a physician within one working day. The court may not order the discontinuation of prescribed psychotropic medication if such order is contrary to the decision of the prescribing physician unless the court first obtains an opinion from a licensed physician stating that more likely than not, discontinuing the medication would not cause significant harm to the child. The court may also order the discontinuation of prescribed psychotropic medication if a child’s treating physician states that continuing the prescribed psychotropic medication would cause significant harm to the child due to a diagnosed, non-psychiatric medical condition.
II. The burden of proof at any hearing held under this paragraph shall be by a preponderance of the evidence.
169-F:10 Emergency Authorization.
I. If the child’s prescribing physician certifies in the signed medical report required in RSA�169-F:8 that delay in providing a prescribed psychotropic medication would more likely than not cause significant harm to the child, the medication may be provided in advance of the issuance of a court order. In such event, the medical report shall provide the specific reasons why the child may experience significant harm and the nature and the extent of the potential harm. The department shall submit a motion seeking continuation of the medication and the physician’s medical report to the court, the child’s guardian ad litem, and all other parties within 3 working days after the department commences providing the medication to the child. The department shall seek the order at the next regularly scheduled court hearing or within 30 days after the date of the prescription, whichever occurs sooner. If any party objects to the department’s motion, the court shall hold a hearing within 7 days.
II. Psychotropic medications may be administered in advance of a court order in children’s hospitals and inpatient psychiatric programs specializing in mental health care for children and adolescents. Within 3 working days after the medication is begun, the department shall seek court authorization as described in RSA 169-F:8.
169-F:11 Status Report; Court Authorization to Continue Treatment.
I. The department shall fully inform the court of the child’s medical and behavioral status as part of the social services report prepared for each review hearing held for a child for whom psychotropic medication has been prescribed or provided under this subdivision. As a part of the information provided to the court, the department shall furnish copies of all pertinent medical records concerning the child which have been generated since the previous hearing.
II. The court may, in the best interests of the child, order the department to obtain a medical opinion addressing whether the continued use of the medication under the circumstances is safe and medically appropriate.
III. The court shall not authorize a psychotropic medication for a child if the medication has not been approved by the FDA for children of that age.
169-F:12 Rulemaking. The department shall adopt rules under RSA 541-A to ensure that children receive timely access to clinically appropriate psychotropic medications. These rules shall include, but need not be limited to:
I. The process for determining which adjunctive services are needed.
II. The uniform process for facilitating the prescribing physician’s ability to obtain the express and informed consent of a child’s parent or guardian.
III. The procedures for obtaining court authorization for the provision of a psychotropic medication.
IV. The frequency of medical monitoring and reporting on the status of the child to the court.
V. How the child’s parents will be involved in the treatment-planning process if their parental rights have not been terminated.
VI. How caretakers are to be provided information contained in the physician’s signed medical report.
VII. Uniform forms to be used in requesting court authorization for the use of a psychotropic medication and provide for the integration of each child’s treatment plan and case plan.
2 Effective Date. This act shall take effect January 1, 2011.
LBAO
10-2041
12/01/09
HB 1536-FN - FISCAL NOTE
AN ACT relative to administering psychotropic drugs to children in court ordered placements.
FISCAL IMPACT:
The Department of Health and Human Services states this bill may increase state expenditures by an indeterminable amount in FY 2011 and each year thereafter. This bill will have no fiscal impact on state, county and local revenue, or county and local expenditures.
METHODOLOGY:
The Department of Health and Human Services (DHHS) states this bill provides for a number of motions, evaluations, reports and hearings that would be required at various states of the process whenever psychotropic medications are to be provided for a child that is in the Department’s legal custody. The Department states while it is likely the bill would increase the number of motions and hearings in these cases and that it would increase provider costs by prescribing the type, number and timing of evaluations, given the number of variables in the bill, DHHS is unable to estimate what the increase in costs or the Federal and State share of such costs. Although an exact fiscal impact cannot be determined at this time, the Department has analyzed the potential impact as it relates to the population at the Sununu Youth Services Center (SYSC). The Department states after extensive conversation with the staff psychiatrist at the SYSC, there could be additional costs of approximately $1,087.50 per case. Such costs would include psychiatrist report writing; copying of youth medical files; transcription of reports, and review and correction by psychiatrist; psychiatrist meetings with Division of Juvenile Justice Services staff attorney; and psychiatrist court time. DHHS projects the number of SYSC cases impacted would total 13 in FY 2011, 14 in FY 2012, and 15 in FY 2013 and each year thereafter, which would result in additional costs of approximately $14,138 in FY 2011, $15,225 in FY 2012, and $16,313 in FY 2013 and beyond. All such costs would be from the state general fund since youth in placement at SYSC are not eligible for federal reimbursement (Title IV-E).
The drugging of our children!!
The drugging of our children!!
Jane Boyer
show details 3:59 PM (12 minutes ago)
Description
Selective Serotonin Reuptake Inhibitors do exactly that: Inhibit the reuptake of serotonin, thus leaving excess serotonin which allows this stimulation to continue. It has long been known that inhibiting the reuptake of serotonin will produce depression, suicide, violence, psychosis, mania, cravings for alcohol and other drugs, reckless driving, etc. The most popular drugs that produce this reuptake of serotonin are: SSRI Antidepressants: Prozac, Serafem, Zoloft, Paxil, Luvox, Celexa, Lexapro SNRI Antidepressants: Effexor, Remeron, Serzone, Cymbalta Atypical Antipsychotics: Zyprexa, Geodon, Abilify, Seroquel, Risperdal Weight Loss Medications: Fen-Phen, Redux, Meridia Pain Killers: (Any opium or heroin derivative) Morphine, OxyContin, Ultram, Tramadol, Percocet, Percodan, Lortab, Demerol, Darvon or Darvocet, Codeine, Buprenex, Dilaudid, Talwin, Stadol, Vicodin, Duragesic Patches, Fentanyl Transdermal, Methadone, Dextromethorphan (commonly used in cough syrups), etc. * * * WARNING * * * Dropping "cold turkey" off any of these medications can be more dangerous than staying on the drugs. Tapering off very, very, very slowly has proven the safest and most effective method of withdrawal. -------------------------------------- This torrent consists of two .mp3 files: Dr. Ann Blake Tracy - Help! I Can't Get Off My Antidepressant!.mp3 (1:19:00, 64kbps, 36.1mb); Dr. Fred Bell & Dr. Ann Blake Tracy - The Shocking Truth About SSRIs.mp3 (0:58:51, 32kbps, 13.4mb) The uploader and internet personality known as "geogaddi00" has instructed me in uploading this very important torrent and brings the news that it has been worked out directly with Dr. Ann Blake Tracy that the copyright for the "Help! I Can't Get Off My Antidepressant!" file has been ignored for the encouragement of podcasters, internet multimedia archivists, radio hosts etc. etc. to broadcast, host and share this file as far and wide as possible. It is very necessary to start getting this information out now a.s.a.p. for many complicated reasons which are brought up within the data in this torrent as well as other online sources. ** http://smarteconomy.typepad.com/smart_economy/2006/09/wild_card_colla.html (possible collapse of US Banking system in 2008) - http://www.healthfreedomusa.org/index.php?page_id=157 (possible implentation of the "Codex Alimentarius" bill which jeopardizes our ability to purchase natural medicine) ** SHARE, SEED, SPREAD, SAVE!!! -------------------------------------- "I am alarmed at the monster that Johns Hopkins neuroscientist Solomon Snyder and I created when we discovered the simple binding assay for drug receptors 25 years ago. Prozac and other antidepressant serotonin-receptor-active compounds may also cause cardiovascular problems in some susceptible people after long-term use, which has become common practice despite the lack of safety studies. "The public is being misinformed about the precision of these selective serotonin-uptake inhibitors when the medical profession oversimplifies their action in the brain and ignores the body as if it exists merely to carry the head around! In short, these molecules of emotion regulate every aspect of our physiology. A new paradigm has evolved, with implications that life-style changes such as diet and exercise can offer profound, safe and natural mood elevation." Candace B. Pert, Research Professor, Georgetown University Medical Center, Washington; Letter to the Editor of TIME Magazine, October 20, 1997, page 8. -------------------------------------- Drugs like Prozac, Zoloft, Paxil, Luvox, Effexor, Serzone, Anafranil, etc. are some of the biggest money makers ever for the pharmaceutical companies. Yet are you aware that the use of Prozac among children from ages 6-12 went from 41,000 in 1995 to 203,000 in 1996. The number of new prescriptions written increased almost 400% in just one year?!! This is a very powerful mind-altering drug that has not been approved for use in children and yet our children are popping it like candy! Just Prozac's affect upon cortisol levels alone should frighten parents to death. One 30mg dose has been shown to clearly double the level of cortisol! (PROZAC PANACEA OR PANDORA?, p. 168) Increased cortisol impairs the development and regeneration of the liver, kidneys and muscles. It also retards linear growth. How many parents are given that information? How many doctors are aware of it themselves? The study being used to gain FDA approval of this medication demonstrates that the rate of mania (a terrible form of insanity including symptoms of sexual compulsions, criminal behavior, alcohol cravings, rages leading to domestic violence, delusions of grandeur - often mistaken for increased self confidence, wild spending and varied types of criminal behavior) among children taking Prozac was three times higher than it is for adults. Three out of 100 had to drop out of the study due to this devastating complication which developed within a short eight week trial! The most logical question to ask is "Why do this to our children when there are many safer natural options that work as well without serious side effects?" -------------------------------------- http://drugawareness.org/ International Coalition For Drug Awareness http://www.ssristories.com/ Database of SSRI Cases of Suicide and Violence (includes high-profile cases such as the Virgina Tech school shooting, the Columbine school shooting, the Phil Hartman murder/suicide and the Andrea Yeates tragedy etc etc etc) Michael Moore obtained a copy of Dr. Tracy's book, "Prozac: Panacea or Pandora? - Our Serotonin Nightamre," at the premier of Bowling For Columbine in Denver, CO. After learning more about these drugs, see his statement from the movie he recently appeared in with Dr. Tracy, Mark Taylor, Neal Bush, and others in the Gary Null production "The Drugging of our Children": http://video.google.com/videoplay?docid=-3609599239524875493&q=DRUGGING%2BOF%2BOUR%2BCHILDREN Subscribe for a free newsletter: http://drugawareness.org/Archives/Miscellaneous/yahooform.html -------------------------------------- PROZAC: PANACEA OR PANDORA? by ANN BLAKE TRACY, PhD NO OTHER BOOK ON THE MARKET EVEN BEGINS TO COMPARE!!! AVAILABLE ONLY BY DIRECT ORDER http://members.aol.com/atracyphd/#sprung1 NOT AVAILABLE IN BOOKSTORES THE REST OF THE STORY ON THE NEW SSRI ANTIDEPRESSANTS PROZAC: PANACEA OR PANDORA? is the product of five years of intensive research, and the cases of approximately 1000 patients on a long-term basis. The author, Ann Blake Tracy holds a Doctorate in Health Sciences with the emphasis on Psychology, and is the director of the International Coalition for Drug Awareness. She has specialized in adverse reactions to serotonergic medications (such as Prozac, Zoloft, Paxil, Luvox, Celexa, Effexor, Serzone, Anafranil, Buspar, Fen-Phen, and Redux to name a few) and has testified before the FDA and congressional subcommittee members on Prozac. She has testified since 1992 as an expert witness in Prozac and other SSRI related court cases around the world. Her first book on the issue was published in 1991. During the last nine years she has participated in innumerable radio, television, newspaper and magazine interviews. We know of no one with such extensive experience and expertise on all of these issues surrounding the SSRI antidepressants as Ann Blake Tracy. LEARN MORE THAN PROFESSIONALS ABOUT THE SSRI ANTIDEPRESSANTS . . . SAFE METHODS TO GET OFF DRUGS, STAY OFF, AND TAKE CONTROL OF LIFE . . . IF YOU KNOW SOMEONE ON PROZAC, ZOLOFT, PAXIL, LUVOX, SERZONE, EFFEXOR, ANAFRANIL, FENFLURAMINE (Fen-Phen and Redux), DESERYL, MERIDIA, OR ANY OTHER DRUG DESIGNED TO INCREASE SEROTONIN, YOU AND THEY BOTH NEED THE INFORMATION CONTAINED IN THIS BOOK. -------------------------------------- Taper off very, very slowly. Dropping "cold turkey" off any medication, most especially mind altering medications, can often be MORE DANGEROUS than staying on the drugs. The most dangerous and most common mistake someone coming off the SSRI antidepressants makes is coming off these drugs too rapidly. Tapering off very, very, VERY SLOWLY--OVER MONTHS (and for long-term users�a year or more), NOT JUST WEEKS!�has proven the safest and most effective method of withdrawal from this type of medication. Thus the body is given the time it needs to readjust its own chemical levels. Patients must be warned to come very slowly off these drugs by shaving minuscule amounts off their pills each day, as opposed to cutting them in half or taking a pill every other day. This cannot be stressed strongly enough! This information on EXTREMELY gradual withdrawal is the most critical piece of information that someone facing withdrawal from these drugs needs to have. A REMINDER: IT IS EASIER TO GET DOWN OFF A MOUNTAINTOP ONE GUARDED STEP AT A TIME THAN TO JUMP FROM THE TOP TO THE BOTTOM. No matter how few or how many side effects you have had on these antidepressants, withdrawal is a whole new world. The worst part of rapid withdrawal does not hit for several months AFTER you quit. So even if you think you are doing okay you quickly find that it becomes much worse. If you do not come off correctly and rebuild your body as you do, you risk: - Creating bouts of overwhelming depression - Producing a MUCH longer withdrawal and recovery period than if you had come off slowly - Overwhelming fatigue causing you to be unable to continue daily tasks or costing your job - Having a psychotic break brought on by the terrible insomnia from the rapid withdrawal, and then being locked in a psychiatric ward - Ending up going back on the drugs (each period on the drugs tends to be more dangerous and problematic than the previous time you were on the drugs) and having more drugs added to calm the withdrawal effects - Seizures and other life threatening physical reactions - Violent outbursts or rages Although the book contains massive amounts of information you can find nowhere else on these drugs, it does not have the extensive amount of information contained in the tape on withdrawal. The tape contains newer and updated information on safe withdrawal from these drugs. The tape details over an hour and a half the safest ways found over the last ten years to withdraw from antidepressants. It also lists many alternative treatments that can assist you in getting though the withdrawal. And it contains information on how to rebuild your health after you have had it destroyed by the drugs so that you never end up on these drugs again. The tape is very inexpensive and will save you thousands in medical bills which you will spend trying to do it on your own. Many have lamented that they wished they would have had the information on this tape before attempting withdrawal. This is a tape doctors can also benefit from when attempting to withdraw their patients from these drugs that the World Health Organization has now told us are addictive and produce withdrawal. ** To get this on CD, or to buy Dr. Ann Blake Tracy's book, go here: http://drugawareness.org/shop/order.html (PayPal supported) To hear the mp3 of this tape/CD and to share it with others, download this torrent! ** -------------------------------------- - Come visit us at www.TorrentBox.com
Jane Boyer
show details 3:59 PM (12 minutes ago)
Description
Selective Serotonin Reuptake Inhibitors do exactly that: Inhibit the reuptake of serotonin, thus leaving excess serotonin which allows this stimulation to continue. It has long been known that inhibiting the reuptake of serotonin will produce depression, suicide, violence, psychosis, mania, cravings for alcohol and other drugs, reckless driving, etc. The most popular drugs that produce this reuptake of serotonin are: SSRI Antidepressants: Prozac, Serafem, Zoloft, Paxil, Luvox, Celexa, Lexapro SNRI Antidepressants: Effexor, Remeron, Serzone, Cymbalta Atypical Antipsychotics: Zyprexa, Geodon, Abilify, Seroquel, Risperdal Weight Loss Medications: Fen-Phen, Redux, Meridia Pain Killers: (Any opium or heroin derivative) Morphine, OxyContin, Ultram, Tramadol, Percocet, Percodan, Lortab, Demerol, Darvon or Darvocet, Codeine, Buprenex, Dilaudid, Talwin, Stadol, Vicodin, Duragesic Patches, Fentanyl Transdermal, Methadone, Dextromethorphan (commonly used in cough syrups), etc. * * * WARNING * * * Dropping "cold turkey" off any of these medications can be more dangerous than staying on the drugs. Tapering off very, very, very slowly has proven the safest and most effective method of withdrawal. -------------------------------------- This torrent consists of two .mp3 files: Dr. Ann Blake Tracy - Help! I Can't Get Off My Antidepressant!.mp3 (1:19:00, 64kbps, 36.1mb); Dr. Fred Bell & Dr. Ann Blake Tracy - The Shocking Truth About SSRIs.mp3 (0:58:51, 32kbps, 13.4mb) The uploader and internet personality known as "geogaddi00" has instructed me in uploading this very important torrent and brings the news that it has been worked out directly with Dr. Ann Blake Tracy that the copyright for the "Help! I Can't Get Off My Antidepressant!" file has been ignored for the encouragement of podcasters, internet multimedia archivists, radio hosts etc. etc. to broadcast, host and share this file as far and wide as possible. It is very necessary to start getting this information out now a.s.a.p. for many complicated reasons which are brought up within the data in this torrent as well as other online sources. ** http://smarteconomy.typepad.com/smart_economy/2006/09/wild_card_colla.html (possible collapse of US Banking system in 2008) - http://www.healthfreedomusa.org/index.php?page_id=157 (possible implentation of the "Codex Alimentarius" bill which jeopardizes our ability to purchase natural medicine) ** SHARE, SEED, SPREAD, SAVE!!! -------------------------------------- "I am alarmed at the monster that Johns Hopkins neuroscientist Solomon Snyder and I created when we discovered the simple binding assay for drug receptors 25 years ago. Prozac and other antidepressant serotonin-receptor-active compounds may also cause cardiovascular problems in some susceptible people after long-term use, which has become common practice despite the lack of safety studies. "The public is being misinformed about the precision of these selective serotonin-uptake inhibitors when the medical profession oversimplifies their action in the brain and ignores the body as if it exists merely to carry the head around! In short, these molecules of emotion regulate every aspect of our physiology. A new paradigm has evolved, with implications that life-style changes such as diet and exercise can offer profound, safe and natural mood elevation." Candace B. Pert, Research Professor, Georgetown University Medical Center, Washington; Letter to the Editor of TIME Magazine, October 20, 1997, page 8. -------------------------------------- Drugs like Prozac, Zoloft, Paxil, Luvox, Effexor, Serzone, Anafranil, etc. are some of the biggest money makers ever for the pharmaceutical companies. Yet are you aware that the use of Prozac among children from ages 6-12 went from 41,000 in 1995 to 203,000 in 1996. The number of new prescriptions written increased almost 400% in just one year?!! This is a very powerful mind-altering drug that has not been approved for use in children and yet our children are popping it like candy! Just Prozac's affect upon cortisol levels alone should frighten parents to death. One 30mg dose has been shown to clearly double the level of cortisol! (PROZAC PANACEA OR PANDORA?, p. 168) Increased cortisol impairs the development and regeneration of the liver, kidneys and muscles. It also retards linear growth. How many parents are given that information? How many doctors are aware of it themselves? The study being used to gain FDA approval of this medication demonstrates that the rate of mania (a terrible form of insanity including symptoms of sexual compulsions, criminal behavior, alcohol cravings, rages leading to domestic violence, delusions of grandeur - often mistaken for increased self confidence, wild spending and varied types of criminal behavior) among children taking Prozac was three times higher than it is for adults. Three out of 100 had to drop out of the study due to this devastating complication which developed within a short eight week trial! The most logical question to ask is "Why do this to our children when there are many safer natural options that work as well without serious side effects?" -------------------------------------- http://drugawareness.org/ International Coalition For Drug Awareness http://www.ssristories.com/ Database of SSRI Cases of Suicide and Violence (includes high-profile cases such as the Virgina Tech school shooting, the Columbine school shooting, the Phil Hartman murder/suicide and the Andrea Yeates tragedy etc etc etc) Michael Moore obtained a copy of Dr. Tracy's book, "Prozac: Panacea or Pandora? - Our Serotonin Nightamre," at the premier of Bowling For Columbine in Denver, CO. After learning more about these drugs, see his statement from the movie he recently appeared in with Dr. Tracy, Mark Taylor, Neal Bush, and others in the Gary Null production "The Drugging of our Children": http://video.google.com/videoplay?docid=-3609599239524875493&q=DRUGGING%2BOF%2BOUR%2BCHILDREN Subscribe for a free newsletter: http://drugawareness.org/Archives/Miscellaneous/yahooform.html -------------------------------------- PROZAC: PANACEA OR PANDORA? by ANN BLAKE TRACY, PhD NO OTHER BOOK ON THE MARKET EVEN BEGINS TO COMPARE!!! AVAILABLE ONLY BY DIRECT ORDER http://members.aol.com/atracyphd/#sprung1 NOT AVAILABLE IN BOOKSTORES THE REST OF THE STORY ON THE NEW SSRI ANTIDEPRESSANTS PROZAC: PANACEA OR PANDORA? is the product of five years of intensive research, and the cases of approximately 1000 patients on a long-term basis. The author, Ann Blake Tracy holds a Doctorate in Health Sciences with the emphasis on Psychology, and is the director of the International Coalition for Drug Awareness. She has specialized in adverse reactions to serotonergic medications (such as Prozac, Zoloft, Paxil, Luvox, Celexa, Effexor, Serzone, Anafranil, Buspar, Fen-Phen, and Redux to name a few) and has testified before the FDA and congressional subcommittee members on Prozac. She has testified since 1992 as an expert witness in Prozac and other SSRI related court cases around the world. Her first book on the issue was published in 1991. During the last nine years she has participated in innumerable radio, television, newspaper and magazine interviews. We know of no one with such extensive experience and expertise on all of these issues surrounding the SSRI antidepressants as Ann Blake Tracy. LEARN MORE THAN PROFESSIONALS ABOUT THE SSRI ANTIDEPRESSANTS . . . SAFE METHODS TO GET OFF DRUGS, STAY OFF, AND TAKE CONTROL OF LIFE . . . IF YOU KNOW SOMEONE ON PROZAC, ZOLOFT, PAXIL, LUVOX, SERZONE, EFFEXOR, ANAFRANIL, FENFLURAMINE (Fen-Phen and Redux), DESERYL, MERIDIA, OR ANY OTHER DRUG DESIGNED TO INCREASE SEROTONIN, YOU AND THEY BOTH NEED THE INFORMATION CONTAINED IN THIS BOOK. -------------------------------------- Taper off very, very slowly. Dropping "cold turkey" off any medication, most especially mind altering medications, can often be MORE DANGEROUS than staying on the drugs. The most dangerous and most common mistake someone coming off the SSRI antidepressants makes is coming off these drugs too rapidly. Tapering off very, very, VERY SLOWLY--OVER MONTHS (and for long-term users�a year or more), NOT JUST WEEKS!�has proven the safest and most effective method of withdrawal from this type of medication. Thus the body is given the time it needs to readjust its own chemical levels. Patients must be warned to come very slowly off these drugs by shaving minuscule amounts off their pills each day, as opposed to cutting them in half or taking a pill every other day. This cannot be stressed strongly enough! This information on EXTREMELY gradual withdrawal is the most critical piece of information that someone facing withdrawal from these drugs needs to have. A REMINDER: IT IS EASIER TO GET DOWN OFF A MOUNTAINTOP ONE GUARDED STEP AT A TIME THAN TO JUMP FROM THE TOP TO THE BOTTOM. No matter how few or how many side effects you have had on these antidepressants, withdrawal is a whole new world. The worst part of rapid withdrawal does not hit for several months AFTER you quit. So even if you think you are doing okay you quickly find that it becomes much worse. If you do not come off correctly and rebuild your body as you do, you risk: - Creating bouts of overwhelming depression - Producing a MUCH longer withdrawal and recovery period than if you had come off slowly - Overwhelming fatigue causing you to be unable to continue daily tasks or costing your job - Having a psychotic break brought on by the terrible insomnia from the rapid withdrawal, and then being locked in a psychiatric ward - Ending up going back on the drugs (each period on the drugs tends to be more dangerous and problematic than the previous time you were on the drugs) and having more drugs added to calm the withdrawal effects - Seizures and other life threatening physical reactions - Violent outbursts or rages Although the book contains massive amounts of information you can find nowhere else on these drugs, it does not have the extensive amount of information contained in the tape on withdrawal. The tape contains newer and updated information on safe withdrawal from these drugs. The tape details over an hour and a half the safest ways found over the last ten years to withdraw from antidepressants. It also lists many alternative treatments that can assist you in getting though the withdrawal. And it contains information on how to rebuild your health after you have had it destroyed by the drugs so that you never end up on these drugs again. The tape is very inexpensive and will save you thousands in medical bills which you will spend trying to do it on your own. Many have lamented that they wished they would have had the information on this tape before attempting withdrawal. This is a tape doctors can also benefit from when attempting to withdraw their patients from these drugs that the World Health Organization has now told us are addictive and produce withdrawal. ** To get this on CD, or to buy Dr. Ann Blake Tracy's book, go here: http://drugawareness.org/shop/order.html (PayPal supported) To hear the mp3 of this tape/CD and to share it with others, download this torrent! ** -------------------------------------- - Come visit us at www.TorrentBox.com
[ Pastcps tee shirt flyers]
Hello
I wanted to share this flyer with you and maybe you can help put this out there for me If you can pass on to other
Prayer is with in all of us
Use it to help empower you life
Thank You
If by anyway you need to talk to me my number is 334-226-0090
Denise owner of PAST.CPS
Be Blessed and Safe
http://pastcps.org
http://my.kidjacked.com/nisey/
http://www.cafepress.com/PASTCPSShop
http://315124.spreadshirt.com/
Saturday, September 18, 2010
California Court of Appeal Affirms Mom's $4.9 Million Award Against Social Services Agency
California Court of Appeal Affirms Mom's $4.9 Million Award Against Social Services Agency
RE: Fogarty-Hardwick v. County of Orange, et al. Superior Court of California, County of Orange Case No. 01CC02379 (Trial before Hon. Ronald L. Bauer, Dept. CX103) In 2007 an Orange County jury returned a $4.9 million verdict in favor of Deanna Fogarty-Hardwick finding that county social workers had lied to the juvenile court in order to cause the removal of Fogarty-Hardwick's young children - 6 and 9 years old at the time. In a unanimous scathing opinion issued Monday, June 14, 2010, Division Three of the Fourth District Court of Appeal noted that the evidence presented at trial led both the judge and jury to conclude that "something seriously wrong had been done to Fogarty-Hardwick" and that the conduct of the social workers was not "an isolated incident." The Court of Appeal went on to chastise the County saying "This conclusion is something that should be taken very seriously.
Read the entire article at:
http://www.prweb.com/releases/Fogarty-Hardwick/social_services/prweb4157254.htm
RE: Fogarty-Hardwick v. County of Orange, et al. Superior Court of California, County of Orange Case No. 01CC02379 (Trial before Hon. Ronald L. Bauer, Dept. CX103) In 2007 an Orange County jury returned a $4.9 million verdict in favor of Deanna Fogarty-Hardwick finding that county social workers had lied to the juvenile court in order to cause the removal of Fogarty-Hardwick's young children - 6 and 9 years old at the time. In a unanimous scathing opinion issued Monday, June 14, 2010, Division Three of the Fourth District Court of Appeal noted that the evidence presented at trial led both the judge and jury to conclude that "something seriously wrong had been done to Fogarty-Hardwick" and that the conduct of the social workers was not "an isolated incident." The Court of Appeal went on to chastise the County saying "This conclusion is something that should be taken very seriously.
Read the entire article at:
http://www.prweb.com/releases/Fogarty-Hardwick/social_services/prweb4157254.htm
Subscribe to:
Comments (Atom)